ArticleClinical therapeutics2021

Response to Letter Regarding Article, "Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial".

Leila Shahbaznejad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.